0002160318-26-000001.txt : 20261112 0002160318-26-000001.hdr.sgml : 20261112 20261112145441 ACCESSION NUMBER: 0002160318-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20261112 DATE AS OF CHANGE: 20261112 EFFECTIVENESS DATE: 20261112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avalon BioVentures II, LP CENTRAL INDEX KEY: 0002160318 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-604534 FILM NUMBER: 261546147 BUSINESS ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-401-3343 MAIL ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0002160318 Avalon BioVentures II, LP 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA CALIFORNIA 92037 858-401-3343 DELAWARE None None Limited Partnership true 2026 N/A Avalon BioVentures II GP, LLC 11099 North Torrey Pines Road, Suite 290 La Jolla CA CALIFORNIA 92037 Director General Partner of the Issuer Tighe Reardon 11099 North Torrey Pines Road, Suite 290 La Jolla CA CALIFORNIA 92037 Director Managing Director of the General Partner of the Issuer Jay Lichter 11099 North Torrey Pines Road, Suite 290 La Jolla CA CALIFORNIA 92037 Director Managing Director of the General Partner of the Issuer Sanford Madigan 11099 North Torrey Pines Road, Suite 290 La Jolla CA CALIFORNIA 92037 Director Managing Director of the General Partner of the Issuer Sergio Duron 11099 North Torrey Pines Road, Suite 290 La Jolla CA CALIFORNIA 92037 Director Managing Director of the General Partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 false true false true false 0 200000000 0 200000000 false 0 0 0 0 The Issuer's General Partner (or its designee) is entitled to a management fee payable by the Issuer. false Avalon BioVentures II, LP /s/ Tighe Reardon Tighe Reardon Managing Director of the General Partner of the Issuer 2026-11-12